AL-335, a Once-Daily Pangenotypic Nucleotide HCV Polymerase Inhibitor, Demonstrates Potent Antiviral Activity over 7 Days in Treatment-Naïve Genotype 1-4 Patients
Berliba, E., Tsertsvadze, T., Ghicavii, N., Guyader, D., Kakabadze, T., Westland, C., Chanda, S., Patat, A., Zhang, Q., Smith, D., Yogaratnam, J., McClure, M., Beigelman, L., Blatt, L., Fry, J.Volume:
64
Year:
2016
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(16)00641-3
File:
PDF, 89 KB
english, 2016